Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease

被引:75
|
作者
Lad, Eleonora M. [1 ]
Mukherjee, Dibyendu [2 ]
Stinnett, Sandra S. [1 ]
Cousins, Scott W. [1 ]
Potter, Guy G. [3 ]
Burke, James R. [3 ]
Farsiu, Sina [1 ,2 ]
Whitson, Heather E. [1 ,4 ]
机构
[1] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC USA
[3] Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源
PLOS ONE | 2018年 / 13卷 / 02期
关键词
OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; SMALL VESSEL DISEASE; VISUAL-FIELD LOSS; AUTOMATIC SEGMENTATION; MULTIPLE-SCLEROSIS; SD-OCT; THICKNESS; DYSFUNCTION; DEMENTIA;
D O I
10.1371/journal.pone.0192646
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inner retina in Alzheimer's Disease (AD) may experience neuroinflammation resulting in atrophy. The objective of our study was to determine whether retinal GCIPL (ganglion cell-inner plexiform layer) or nerve fiber layer (NFL) thickness may serve as noninvasive bio-markers to diagnose AD. This cross-sectional case-control study enrolled 15 mild cognitive impairment (MCI) patients, 15 mild-moderate AD patients, and 18 cognitively normal adults. NFL and GCIPL thicknesses on optical coherence tomography (OCT) were measured using Duke Optical Coherence Tomography Retinal Analysis Program (DOCTRAP) and Spectralis software. We demonstrated that regional thicknesses of NFL or GCIPL on macular or nerve OCTs did not differ between groups. However, a multi-variate regression analysis identified macular areas with a significant thickening or thinning in NFL and GCIPL in MCI and AD patients. Our primary findings controvert previous reports of thinner NFL in moderate-to-severe AD. The areas of thickening of GCIPL and NFL in the macula adjacent to areas of thinning, as revealed by a more complex statistical model, suggest that NFL and GCIPL may undergo dynamic changes during AD progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Biomarkers of mild cognitive impairment and Alzheimer's disease
    Tang, Bor Luen
    Kumar, Rajeev
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 406 - 410
  • [2] IDENTIFICATION OF BIOMARKERS OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
    Giraldo, E.
    Lloret, A.
    Badia, M. C.
    Fuchsberger, T.
    Garcia, J.
    Alonso, D.
    Vina, J.
    ACTA PHYSIOLOGICA, 2014, 212 : 70 - 71
  • [3] Plasma biomarkers for mild cognitive impairment and Alzheimer's disease
    Song, Fei
    Poljak, Anne
    Smythe, George A.
    Sachdev, Perminder
    BRAIN RESEARCH REVIEWS, 2009, 61 (02) : 69 - 80
  • [4] Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis
    Ge, Yi-Jun
    Xu, Wei
    Ou, Ya-Nan
    Qu, Yi
    Ma, Ya-Hui
    Huang, Yu-Yuan
    Shen, Xue-Ning
    Chen, Shi-Dong
    Tan, Lan
    Zhao, Qian-Hua
    Yu, Jin-Tai
    AGEING RESEARCH REVIEWS, 2021, 69
  • [5] Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
    Hu, William T.
    Chen-Plotkin, Alice
    Arnold, Steven E.
    Grossman, Murray
    Clark, Christopher M.
    Shaw, Leslie M.
    Pickering, Eve
    Kuhn, Max
    Chen, Yu
    McCluskey, Leo
    Elman, Lauren
    Karlawish, Jason
    Hurtig, Howard I.
    Siderowf, Andrew
    Lee, Virginia M. -Y.
    Soares, Holly
    Trojanowski, John Q.
    ACTA NEUROPATHOLOGICA, 2010, 119 (06) : 669 - 678
  • [6] Imaging and Biomarkers in Early Alzheimer's Disease and Mild Cognitive Impairment
    Petersen, R. C.
    Jack, C. R., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 438 - 441
  • [7] Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
    Kesler, Anat
    Vakhapova, Veronika
    Korczyn, Amos D.
    Naftaliev, Elvira
    Neudorfer, Meira
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (07) : 523 - 526
  • [8] Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer’s disease
    Christian Luckhaus
    Bijan Mahabadi
    Brigitte Grass-Kapanke
    Michaela Jänner
    Holger Willenberg
    Marcus Jäger
    Tillmann Supprian
    Karin Fehsel
    Journal of Neural Transmission, 2009, 116 : 905 - 911
  • [9] Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
    William T. Hu
    Alice Chen-Plotkin
    Steven E. Arnold
    Murray Grossman
    Christopher M. Clark
    Leslie M. Shaw
    Eve Pickering
    Max Kuhn
    Yu Chen
    Leo McCluskey
    Lauren Elman
    Jason Karlawish
    Howard I. Hurtig
    Andrew Siderowf
    Virginia M.-Y. Lee
    Holly Soares
    John Q. Trojanowski
    Acta Neuropathologica, 2010, 119 : 669 - 678
  • [10] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166